Nuveen, LLC Terns Pharmaceuticals, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 1,405,901 shares of TERN stock, worth $4.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,405,901Holding current value
$4.86 Million% of portfolio
0.0%About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $130M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...